Brief: Cytek Biosciences Q4 Pretax Profit USD -4.031 Million
26/02/2026 21:05
Feb 26 (Reuters) - Cytek Biosciences Q4 net income USD -44.076 million. Q4 adjusted gross margin 53% Q4 adjusted EBITDA USD 4.491 million outlook FY revenue USD 205-212 million
Recent news on Cytek Biosciences
See all newsCytek owes Beckman Coulter $56 mln in cell-analysis patent case, US jury says (updated)
Cytek owes Beckman Coulter $56 mln in cell-analysis patent case, US jury says
Cytek Biosciences, Inc. reports results for the quarter ended June 30 - Earnings Summary
Cytek Biosciences Q2 revenue slightly misses estimates
Brief: Cytek Biosciences Q2 Revenue USD 48.14 Million